(Q39679240)

13 September 2017

1 reference

title

Subdivisions of idiopathic autoimmune chronic active hepatitis (English)

1 reference

13 September 2017

Maddrey WC

1

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 November 1987

1 reference

13 September 2017

1 reference

13 September 2017

volume

7

1 reference

13 September 2017

issue

6

1 reference

13 September 2017

page(s)

1372-1375

1 reference

CHRONIC ACTIVE ("LUPOID") HEPATITIS; A CLINICAL, SEROLOGICAL, AND PATHOLOGICAL STUDY OF 20 PATIENTS.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

ACTIVE 'JUVENILE' CIRRHOSIS CONSIDERED AS PART OF A SYSTEMIC DISEASE AND THE EFFECT OF CORTICOSTEROID THERAPY

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

https://api.crossref.org/works/10.1002%2FHEP.1840070631

1 reference

7 January 2021

Natural history, clinical features, and treatment of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Association of autoimmune active chronic hepatitis with HL-A1,8.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

HLA Determinants in Chronic Active Liver Disease: Possible Relation of HLA-Dw3 to Prognosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Genetic determinants of autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Hepatic Disorders Associated with Liver/Kidney Microsomal Antibodies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Anti-liver-kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Liver membrane autoantibodies in chronic active hepatitis. Studies on mechanically and enzymatically isolated rabbit hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

The L.E.-cell phenomenon in active chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

The immunologic diagnosis of chronic active "autoimmune" hepatitis: distinction from systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Frequency and significance of antibody to double-stranded DNA in chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Autoantibodies against liver-specific membrane lipoprotein in acute and chronic liver diseases: studies on organ-, species-, and disease-specificity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Antibody to liver membrane antigens in chronic active hepatitis. IV. Exclusion of specific reactivity to polypeptides and glycolipids by immunoblotting

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

The immunopathology of autoimmune and hepatitis B virus-induced chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Approaches to the treatment of hepatitis B virus and delta-related liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Expression of beta 2-microglobulin on hepatocytes in acute and chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Persistent measles virus genome in autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Raised antibody titres to measles and rubella viruses in chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Measles-virus proteins in the brain tissue of patients with subacute sclerosing panencephalitis: absence of the M protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Drug-induced chronic liver disease, with emphasis on chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Nitrofurantoin-induced chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Trigger factors and HL-A antigens in chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Nitrofurantoin: another cause of drug-induced chronic active hepatitis? A report of a patient with HLA-B8 antigen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

The Role of Acute Hepatitis Type A, B, and Non-A Non-B in the Development of Chronic Active Liver Disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Chronic hepatitis as a first manifestation of Wilson's disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840070631

7 January 2021

Identifiers

DOI

10.1002/HEP.1840070631

1 reference

13 September 2017

1 reference